PURLs: An alternative to warfarin for patients with PE
- PMID: 23313993
- PMCID: PMC3601685
PURLs: An alternative to warfarin for patients with PE
Abstract
Rivaroxaban appears to be as safe and effective as warfarin, without the need for lab monitoring.
Comment on
-
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.N Engl J Med. 2012 Apr 5;366(14):1287-97. doi: 10.1056/NEJMoa1113572. Epub 2012 Mar 26. N Engl J Med. 2012. PMID: 22449293 Clinical Trial.
References
-
- Buller HR, Prins MH, Lensin AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012;366:1287–1297.. EINSTEIN-PE Investigators; - PubMed
-
- Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585–593.. - PubMed
-
- Beckman MG, Hooper WC, Critchley SE, et al. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(suppl):S495–S501.. - PubMed
-
- Bauersachs R, Berkowitz SD, Brenner B, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363:2499–2510.. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
